Tim Stover
Keine laufenden Positionen mehr
Vermögen: - $ am 31.03.2024
Profil
Tim Stover's former job positions include Director-Financial Reporting at Sucampo Pharmaceuticals LLC, Associate Director-External Reporting at Iridium Communications, Inc., Executive Director & Corporate Controller at Autolus Therapeutics Plc, and Senior Manager at Ernst & Young LLP.
He is currently serving as the Chief Financial & Accounting Officer at NexImmune, Inc. from 2023 to 2024.
Mr. Stover completed his graduate degree at American University and his undergraduate degree at Wittenberg University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NEXIMMUNE, INC.
-.--% | 01.03.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Ehemalige bekannte Positionen von Tim Stover
| Unternehmen | Position | Ende |
|---|---|---|
| NEXIMMUNE, INC. | Director of Finance/CFO | 16.04.2024 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
| IRIDIUM COMMUNICATIONS INC. | Corporate Officer/Principal | - |
| SUCAMPO PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | - |
| AUTOLUS THERAPEUTICS PLC | Director/Board Member | - |
Ausbildung von Tim Stover
| Wittenberg University | Undergraduate Degree |
| American University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| NEXIMMUNE, INC. | Health Technology |
| AUTOLUS THERAPEUTICS PLC | Health Technology |
| IRIDIUM COMMUNICATIONS INC. | Communications |
| Private Unternehmen | 2 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Sucampo Pharmaceuticals, Inc.
 Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
